...
首页> 外文期刊>Human Molecular Genetics >Imprinting and assisted reproductive technology.
【24h】

Imprinting and assisted reproductive technology.

机译:烙印和辅助生殖技术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the past 25 years, the frequency of assisted reproductive technology (ART) births has increased rapidly to account for 1-2% of all births in many developed countries. ART procedures such as in vitro fertilization and intracytoplasmic sperm injection are generally considered to be safe, but recent studies suggest a small excess of birth defects and low-birth weight in ART children. In addition, several clinical studies have reported an increased frequency of ART conceptions among children with Beckwith-Wiedemann syndrome or Angelman syndrome caused by an imprinting defect. Although these studies require further confirmation, they are consistent with animal studies reporting disordered expression and epigenetic changes in imprinted genes following in vitro embryo culture. The absolute risk of an imprinting disorder after ART appears to be very small, but further data are required to determine whether the association between ART and human imprinting disorders reflects the effect of embryo culture (or some other aspect of ART) and/or a common mechanism for infertility and imprinting disorders. Retinoblastoma and neurodevelopmental defects have been only tentatively linked to ART, but in view of the role of epigenetic processes in the regulation of gene expression in development and cancer, further research is required into long-term health outcomes for ART children and the epigenetic consequences of ART protocols.
机译:在过去的25年中,辅助生殖技术(ART)的出生频率迅速增加,在许多发达国家中占所有出生的1-2%。一般认为,体外受精和胞浆内精子注射等抗逆转录病毒疗法是安全的,但最近的研究表明,抗逆转录病毒疗法儿童的出生缺陷和低出生体重过少。另外,一些临床研究已经报道了由印记缺陷引起的患有Beckwith-Wiedemann综合征或Angelman综合征的儿童中ART观念的频率增加。尽管这些研究需要进一步确认,但它们与动物研究一致,后者报道了体外胚胎培养后印迹基因中的表达紊乱和表观遗传变化。 ART后出现印迹障碍的绝对风险似乎很小,但需要进一步的数据来确定ART与人类印迹障碍之间的关联是否反映了胚胎培养(或ART的某些其他方面)和/或常见的影响不育和烙印障碍的机制。视网膜母细胞瘤和神经发育缺陷只是暂时性地与ART相关联,但是鉴于表观遗传过程在发育和癌症中基因表达调控中的作用,需要进一步研究ART儿童的长期健康结果以及ART协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号